Emerging Vision, Inc. (fka ISEE)

[ClayTrader]

* * $ISEE Video Chart 11-20-19 * *

Link to Video - click here to watch the technical chart video

[swampboots]

4.25 chartist control this actual likely failed drug, as fumes from endpoint data reflect odds of probable failure.

[deadjim]

3.70s. Killer.. had me concerned for a bit

[deadjim]

3.50s holy shiiiiiiiiiiiii.. She gonna hold this time??

[deadjim]

Pushing through 3.40s.. amazing. Let’s see it smash highs

[swampboots]

Dew is so correct, I dislike the false impressions unchallenged by many sites which carried that misleading PR.

[DewDiligence]

…miraculously, it works here.

I would respectfully disagree—please see #msg-152020152.

[deadjim]

if fill gap then nhods and 4s break coming..less go

[deadjim]

would like to see a push through 3.30s, oh snap there it goes as i type

[deadjim]

There’s the low IF shes zooming back up today

[swampboots]

OPHT was earlier name when 2 drugs had total failure, new drug was repurposed from wet macular degeneration to dry type...miraculously it works here.

[deadjim]

Well there’s 4 even if I couldn’t sell it.. thinking morning dip and rip

[deadjim]

For example I see now this is OPHT — I remember the symbol. Still not familiar with the company though. Lol

[deadjim]

I generally hate ihub, and I can’t really use other opinions but my own but I enjoy discussion. I honestly just know very little. I still have to go back and see why this gapped down, and what the market cap was back then. I’d have to check market gap at the top of base and bottom.. these splits get tricky especially on big pops like this. Just gotta ride it as long as it stays ahead of your position

[swampboots]

Only few times a decade do I take off my boots and pander to the public to offer sure shot victory laps before the race, but you can see I was only one on IHUB who moved the needle with non chart DD and went over the top promoting , which is not my DNA on IHUB.
So best you can o this end, is now is hope I find another in next 10 years to oracle some nice tidy profit.

[deadjim]

I don’t know anything about that. I don’t disagree, but All i see is a biotech that did a reverse split, has low OS with news, and a loonnnnggg collapse period from a gap that happened years ago. I’d have to do too much digging to figure this one out. I like their cash position, but I appreciate any discussion on company direction and history. Hopefully I can continue to nail the trade here, it’ll get harder shortly

[swampboots]

ISEE true market cap rose from 40 million to almost 140 million, but the drugs for the wet version by Lucentis garner over a billion in revenues and only 15% of macular degeneration population, as opposed to this DRY version application comprising 90% of that population. And from my observations with limited parties as a non-medical person, the endpoint bar is very low for this unmet remedy for this nasty disease.
Inveric just have to peddle this statistical significance into final approval or merge with their betters to endure eons of royalties.
I see more kisses after some conferences shinning lights and (to be frank)media momentum by reporters imbued with creating startling over the top sensational headlines.

[swampboots]

ISEE true market cap rose from 40 million to almost 140 million, but the drugs for the wet version by Lucentis garner over a billion in revenues and only 15% of macular degeneration population, as opposed to this DRY version application comprising 90% of that population. And from my observations with limited parties as a non-medical person, the endpoint bar is very low for this unmet remedy for this nasty disease.
Inveric just have to peddle this statistical significance into final approval or merge with their betters to endure eons of royalties.
I see more kisses after some conferences shinning lights and media momentum.

[deadjim]

Thinkin 4s outta gate and sit back a little.. I sold half of my position so hope the rest doesn’t slam me

[swampboots]

ISEE make that an even 3.80 right this minute.

[deadjim]

new hires = new highs.3.79 ohhhh daaamn

[swampboots]

ISEE 3.60, cash plus, only remedy for 15 million, no incentive to short ++$$$$$$$$$$.different bird comes every 5 years or so.

[deadjim]

Could go either way. Seen them go another 300% or tank after the first run.

[stockdawg44]

trading millions and millions of shares today, should be at $6+ w the volume, float etc. etc....seen this type of action before several times

[deadjim]

Why do you think that?

[stockdawg44]

i still think an offering or diluted shares hit the market, either way it's been a good trader play.....

[deadjim]

She’s strong

[stockdawg44]

I flipped a few, easy in/out all day long....to me it appears it's trading like an offering or diluting is happening.

The slow rise to new highs, all this volume and the swings .....90 to $3.30+, day 3 of the run.....

my take

[deadjim]

I’m surprised how much cash these guys have. Was there a raise recently at some point? These are the questions I ask myself because this board is dead

[deadjim]

There’s the .90s test... If it retest it may have a nice quick flip to the downside but new hires could send it to fours or five

[deadjim]

I SEE it happening as long as it holds 2.90s.. Do it

[deadjim]

can she squeeze to nhods?

[saj]

the Nov 2.5 calls had a nice bump today

[swampboots]

ISEE 3.03 just keeping track to measure my early odd enthusiasm.

[swampboots]

ISEE 2.41 sellers rare.

[swampboots]

Just to be fair this is something to consider at this time of near triple of lows before the news:



DewDiligence Member Level Tuesday, 10/29/19 06:16:22 PM
Re: swampboots post# 226558 0
Post # of 226566



ISEE isn’t getting much respect because it’s the renamed OPHT, whose Fovista failed horrifically in wet AMD (#msg-148256773, #msg-127913009, #msg-127173982, #msg-133812911).

As for Zimura... it, too, was a wet-AMD drug that’s been repurposed for dry AMD (https://www.mdmag.com/medical-news/zimura-lucentis-combo-safe-but-company-decides-not-to-move-forward ); it might work, of course, but I wouldn’t bank on it.


Respond | View Replies (1)

[swampboots]

ISEE 2,25 HOD only man in universe telling whole story get only part of big big picture. A stock with some cash with only remedy for unmet huge need can only bounce from any price before new data repudiates.....Only few times a decade something like this occurs.

[saj]

ISEE the price moving up :)

[swampboots]

And to point out , the ISEE drug showing a positive can be compelling to millions:

“Geographic atrophy involving the center of the macula is arguably the most unmet need in the treatment of macular degeneration. Patients report trouble reading, trouble functioning in dim environments and seeing blind spots or scotomas that slowly enlarge,” notes Dr. Aleksandra Rachitskaya, an ophthalmologist and retina specialist with Cleveland Clinic."

[swampboots]

You know little of what's big,lol.

[saj]

Remembering when OPHT dropped at the end of 2016, surprised it hasn't popped higher yet

[swampboots]

ISEE 1.53 to now 1.87, true (honest) supply and demand now.

[swampboots]

OT: Yikes :I'm only one on IHUB who can SEE?

[swampboots]

ISEE :could it be, no predatory schemers painting and scalping?

[swampboots]

ISEE 1.58 , yet better color:

https://seekingalpha.com/article/4057593-buy-ophthotech-get-cash-zimura-free

[swampboots]

ISEE more color:
https://www.fiercebiotech.com/biotech/ophthotech-now-iveric-hits-eye-drug-goals-as-shares-jump-for-tiny-biotech

[swampboots]

ISEE 1.65 again from 1.99, stay back, I'll play alone, as notable Lucentis and Eyelea only treat wet Macular Degeneration, just 15% of all cases, and they have billion dollar drug.

ISEE is huge as only game in town for the victims of this disease.

[swampboots]

ISEE Co: site release:
https://investors.ivericbio.com/news-releases/news-release-details/iveric-bios-zimurar-novel-complement-c5-inhibitor-met-its

[swampboots]

ISEE in a small 1.61 very volatile both ways now.